GSK plc GSK
NYSE GSK
$48.68 -0.08 (-0.16%)
At close: Oct 29, 2026 · 4:00 PM EDT

Gsk (GSK) EBT Margin (2009 - 2026)

Updated

Gsk (GSK) reported EBT Margin of 21.77% for the quarter ended Sep 30, 2026, down 6.96 percentage points from 28.74% a year earlier but up 17.56 percentage points from the prior quarter.

Analysis

Gsk (GSK) EBT Margin (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Gsk's EBT Margin came in at 20.54%, down 1.35 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 22.66%, up 11.57 percentage points from the prior year.

  • EBT Margin has a five-year change of +1.43 percentage points (years ended Dec 2020 to Dec 2025).
  • By year, EBT Margin came in at 11.08% in the year ended Dec 31, 2024 (-8.91 pp), 19.99% in the year ended Dec 31, 2023 (+0.80 pp), 19.19% in the year ended Dec 31, 2022 (+4.62 pp) and 14.57% in the year ended Dec 31, 2021 (-6.66 pp).
  • Five-year quarterly EBT Margin spans a low of 0.80% in the quarter ended Sep 30, 2024 and a high of 29.12% in the quarter ended Mar 31, 2022.
  • Year over year, EBT Margin gained in six of the last eight quarters, with an average year-over-year change of +4.23 percentage points.
  • The high point for year-over-year EBT Margin in five years was the quarter ended Sep 30, 2025 (a gain of 27.94 percentage points); the low point was the quarter ended Sep 30, 2024 (a drop of 21.18 percentage points).
  • Per Business Quant data, the three quarters before the quarter ended Sep 30, 2026 came in at 4.21% (quarter ended Jun 30, 2026), 28.10% (quarter ended Mar 31, 2026) and 22.66% (quarter ended Dec 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,264.17 Bn 1,237.79 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 660.04 Bn 579.90 Bn 17.30 Bn 0.13%
3 AbbVie 521.06 Bn 494.17 Bn 12.70 Bn 25.18%
4 Merck 370.60 Bn 370.60 Bn - -
5 Novartis Ag 311.97 Bn 285.20 Bn - -
6 Astrazeneca 288.69 Bn 262.37 Bn 12.86 Bn 18.19%
7 Amgen 252.29 Bn 207.69 Bn 7.24 Bn 27.53%
8 Gilead Sciences 213.47 Bn 213.47 Bn - -
9 Pfizer 173.68 Bn 120.32 Bn 10.94 Bn -4.34%
10 Gsk 100.27 Bn 83.11 Bn 8.73 Bn 21.77%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 21.77%
Jun 30, 2026 4.21%
Mar 31, 2026 28.10%
Dec 31, 2025 22.66%
Sep 30, 2025 28.74%
Jun 30, 2025 23.63%
Mar 31, 2025 28.05%
Dec 31, 2024 6.94%
Sep 30, 2024 0.80%
Jun 30, 2024 18.96%
Mar 31, 2024 18.40%
Dec 31, 2023 4.71%
Sep 30, 2023 21.98%
Jun 30, 2023 27.68%
Mar 31, 2023 27.43%
Dec 31, 2022 22.04%
Sep 30, 2022 12.93%
Jun 30, 2022 12.93%
Mar 31, 2022 29.12%
Dec 31, 2021 4.28%
API Access

Gsk EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=GSK&period=max&api_key=YOUR_API_KEY